Global Cancer Vaccines Competitive Landscape Report 2023: Comprehensive Insights About 250+ Companies and 300+ Drugs
03 mai 2023 07h08 HE
|
Research and Markets
Dublin, May 03, 2023 (GLOBE NEWSWIRE) -- The "Cancer Vaccines - Competitive landscape, 2023" report has been added to ResearchAndMarkets.com's offering. This "Cancer Vaccines - Competitive...
Evaxion Announces Increased Focus and Fast-Tracking of its New AI Discovery to Patients
28 mars 2023 07h46 HE
|
Evaxion Biotech
New AI discovery de-risking the pipeline through faster validation and has potential to enter clinical Phase 1/2a in Q4 2023Phase 2b clinical trial reduced in size and expected to reach interim data...
Evaxion Biotech to announce clinical data for the personalized DNA cancer vaccine EVX-02 at the 2023 American Association for Cancer Research Annual Meeting (AACR)
14 mars 2023 16h30 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, March 14, 2023 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of...
Evaxion receives FDA fast-track designation for personalized cancer immunotherapy
19 janv. 2023 08h45 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of...
Evaxion receives approval from FDA to proceed with the clinical Phase 2b study for EVX-01
03 janv. 2023 07h30 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of...
Global Cancer Vaccine Market & Clinical Trials Outlook 2028: Featuring Key Players AstraZeneca, BioNTech, Merck & Others
26 juil. 2022 07h43 HE
|
Research and Markets
Dublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Vaccine Market & Clinical Trials Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The global cancer...
Global Cancer Vaccine Platforms Market Research Report 2022 Featuring eTheRNA, Merck's Keytruda, Moderna, GSK, OSE Immunotherapuetics, Northwest Biotherapeutics, Sanofi, BioNtech, & Roche
12 mai 2022 04h38 HE
|
Research and Markets
Dublin, May 12, 2022 (GLOBE NEWSWIRE) -- The "Cancer Vaccine Platforms" report has been added to ResearchAndMarkets.com's offering. This report forecasts that cancer vaccines market will witness a...
Global Neoantigen Cancer Vaccine Market Report 2022: Focus on Approach, Line of Therapy, Type, Application, Treatment Strategy and Country-Wise Analysis
18 avr. 2022 04h18 HE
|
Research and Markets
Dublin, April 18, 2022 (GLOBE NEWSWIRE) -- The "Global Neoantigen Cancer Vaccine Market Analysis and Forecasts 2024-2031" report has been added to ResearchAndMarkets.com's offering. The neoantigen...
Global Personalized Medicine Market Report 2021-2030 with Profiles of 300 Companies Along with 583 Collaborations
01 déc. 2021 04h08 HE
|
Research and Markets
Dublin, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The "Personalized Medicine - Scientific & Commercial Aspects" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This...
Global Personalized Medicine Market (2020 to 2030) - Profiles of 298 Companies Along With 583 Collaborations
22 avr. 2021 05h33 HE
|
Research and Markets
Dublin, April 22, 2021 (GLOBE NEWSWIRE) -- The "Personalized Medicine - Scientific & Commercial Aspects" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. The...